The Journal of Maternal-Fetal & Neonatal Medicine, 35(18), 3415-3423
Belle does not charge a separate monthly membership fee
Adverse events: The FDA identified more than 900 cases of adverse health events linked directly to compounded tirzepatide and semaglutide, including at least 17 confirmed patient deaths.* Alternative delivery forms: The FDA only approves authentic tirzepatide as an under-the-skin (subcutaneous) injection
Do Not Use Mounjaro If You Have A personal or family history of medullary thyroid carcinoma Multiple Endocrine Neoplasia syndrome type 2 A serious allergic reaction to tirzepatide or any ingredient in Mounjaro Warnings and Precautions Mounjaro shares the same safety profile as Zepbound including warnings about pancreatitis, hypoglycemia (particularly with insulin or sulfonylureas), gallbladder disease, acute kidney injury, hypersensitivity reactions, severe GI disease, hormonal contraceptive interactions, diabetic retinopathy complications, and delayed gastric emptying increasing aspiration risk during anesthesia
Wegovy and Ozempic both contain the same active ingredient (semaglutide), but they have different FDA-approved indications for use